PERGOLIDE - TREATMENT OF CHOICE IN RESTLESS-LEGS-SYNDROME (RLS) AND NOCTURNAL-MYOCLONUS-SYNDROME (NMS) - LONG-TERM FOLLOW-UP ON PERGOLIDE -SHORT COMMUNICATION

Authors
STAEDT J HUNERJAGER H RUTHER E STOPPE G
Citation
J. Staedt et al., PERGOLIDE - TREATMENT OF CHOICE IN RESTLESS-LEGS-SYNDROME (RLS) AND NOCTURNAL-MYOCLONUS-SYNDROME (NMS) - LONG-TERM FOLLOW-UP ON PERGOLIDE -SHORT COMMUNICATION, Journal of neural transmission, 105(2-3), 1998, pp. 265-268
Citations number
12
Categorie Soggetti
Clinical Neurology",Neurosciences
Journal title
Journal of neural transmission → ACNP
ISSN journal
03009564
Volume
105
Issue
2-3
Year of publication
1998
Pages
265 - 268
Database
ISI
SICI code
0300-9564(1998)105:2-3<265:P-TOCI>2.0.ZU;2-C
Abstract
Pergolide has proven significantly superior to L-dopa plus peripheral decarboxylase inhibitor in short-term therapy of RLS/NMS. We now first present long-term follow-up sleep data showing its lastingly good eff ects after averagely 517 treatment days.